Hyloris Pharmaceuticals Investor Relations Material
Latest events
Investor Presentation
29 Mar, 2025
H2 2024
20 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hyloris Pharmaceuticals SA
Access all reports
Hyloris Pharmaceuticals SA is a Belgian specialty pharmaceutical company that develops reformulated and repurposed medicines. Its portfolio focuses on improving existing drugs to address unmet clinical needs across hospital and emergency care settings. The company engages in regulatory development and commercialization through partnerships. It is headquartered in Liège, Belgium, and its shares are listed on the EURONEXT Brussels.
Key slides for Hyloris Pharmaceuticals SA
Investor Presentation
Hyloris Pharmaceuticals SA
Investor Presentation
Hyloris Pharmaceuticals SA
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
HYL
Country
🇧🇪 Belgium